 |
|
A Pharmacologic and Toxicological Study of Amygdalin
Charles G. Moertel, MD;
Matthew M. Ames, PhD;
John S. Kovach, MD;
Thomas P. Moyer, PhD;
Joseph R. Rubin, MD;
John H. Tinker, MD
JAMA. 1981;245(6):591-594.
Abstract
Six patients with advanced cancer were treated with amygdalin (laetrile) at dosages similar to those employed by laetrile practitioners. Amygdalin given intravenously at 4.5 g/sq m/day was largely excreted unchanged in the urine and produced no clinical or laboratory evidence of toxic reaction. Amygdalin given orally at 0.5 g three times daily produced significant blood cyanide levels to 2.1 µg/mL. No clinical or laboratory evidence of toxic reaction was seen in the six patients taking oral amygdalin at this dosage. One patient, however, challenged with a large intake of raw almonds, had transient symptoms of cyanide toxic reaction with escalating blood cyanide levels. This small study indicates that amygdalin in the doses employed produces few clinical side effects. A definite hazard of cyanide toxic reaction must be assumed, however, and possible long-term side effects remain unknown.
(JAMA 1981;245:591-594)
Author Affiliations
From the Departments of Oncology (Drs Moertel, Ames, Kovach, Moyer), Laboratory Medicine (Dr Moyer), and Anesthesiology (Dr Tinker), Mayo Clinic and Mayo Foundation, Rochester, Minn.
Footnotes
Reprint requests to Comprehensive Cancer Center, Mayo Clinic, Rochester, MN 55901 (Dr Moertel).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Life-Threatening Interaction Between Complementary Medicines: Cyanide Toxicity Following Ingestion of Amygdalin and Vitamin C
Bromley et al.
The Annals of Pharmacotherapy 2005;39:1566-1569.
ABSTRACT
| FULL TEXT
Evaluating Complementary and Alternative Medicine: The Limits of Science and of Scientists
Hufford
J Law Med Ethics 2003;31:198-212.
Safety Issues in Using Complementary and Alternative Medicine
Markman
JCO 2002;20:39s-41.
ABSTRACT
| FULL TEXT
Interactions Between Academic Oncology and Alternative/Complementary/Integrative Medicine: Complex But Necessary
Markman
JCO 2001;19:52s-53.
FULL TEXT
Research on Complementary/Alternative Medicine for Patients With Breast Cancer: A Review of the Biomedical Literature
Jacobson et al.
JCO 2000;18:668-668.
ABSTRACT
| FULL TEXT
Court-Ordered Reimbursement for Unproven Medical Technology: Circumventing Technology Assessment
Ferguson et al.
JAMA 1993;269:2116-2121.
ABSTRACT
Laetrile-Induced Agranulocytosis
Liegner et al.
JAMA 1981;246:2841-2842.
ABSTRACT
|
